Intravenous Access Devices Market to Grow at a CAGR of 5.22% to 2022 Says at MarketResearchNest.com

MarketResearchNest.com adds “Global Intravenous Access Devices Market 2017-2021” new reports to its research database. The report spread across 98 pages with tables and figures in it.

The analysts forecast the global intravenous access devices market to grow at a CAGR of 5.22% during the period 2017-2021.

Intravenous access devices can be inserted into peripheral or central veins for the administration of fluids and nutritional compounds (hyperalimentation); delivery of medications such as antibiotics, chemotherapy drugs, and other intravenous drugs; blood transfusions; and blood collection for diagnostic purpose. Vascular access is one of the essential components of patient care in both hospitals and ambulatory care centers. Intravenous access devices are most commonly used for administration of fluids and nutritional compounds, delivery of medications, blood transfusions, and blood collection for diagnostic purpose. Intravenous access devices are thin tubes made of medical grade materials such as plastic, silicone rubber, polyvinyl chloride (PVC), and nylon. Various intravenous access devices are available, which can be inserted peripherally or centrally, for the safe and reliable venous access in daily clinical practice.

Commenting on the report, an analyst team said: “The latest trend gaining momentum in the market is Rise in popularity of antimicrobial-coated CIVCs. Intravenous access devices are essential for providing fluids, medications, and intravenous nutrition. They are also used to provide cancer treatment to patients. Intravenous access devices such as CIVCs are longer and reach deeper into the major veins of the body. They provide secure and durable intravenous access. However, CRBSIs and thrombosis are common in patients with CVCs. They have a significant impact on the market. This includes increasing healthcare expenses and morbidity and mortality in hospitalized patients.”Request a Sample Report Copy athttps://www.marketresearchnest.com/requestsample.php?reportid=285074 .

According to the report, one of the major drivers for this market is Increase in number of hospitalizations. The number of hospitalizations is increasing across the world. This is due to the growth of the global population and the increasing prevalence of various acute and chronic diseases. In the US, the total number of inpatient hospitalizations increased by 15% from 31.7 million in 2000 to 36.5 million in 2012. According to the CDC, in 2014, there were 141.4 million emergency department visits that resulted in 11.2 million hospital admissions and 1.8 million critical care unit admissions in the US. In 2014, about 20 million people visited physicians’ offices for cancer as the primary diagnosis, 17.8 million people visited physicians’ offices and 3.9 million people visited hospital outpatient departments due to infectious and parasitic diseases in the US. According to the CDC, in 2015, 4.9 million adults were diagnosed with kidney diseases in the US.

Further, the report states that one of the major factors hindering the growth of this market is Complications associated with intravenous access devices. Intravenous access devices such as intravenous catheters are found to be the most common sources of bacteremia and fungemia. Intravenous catheters predispose the patient to the risks of local and systemic infections such as CRBSIs, septic thrombophlebitis, endocarditis, and other metastatic infections such as lung abscess, brain abscess, osteomyelitis, and endophthalmitis. Infiltration, phlebitis, and dislodgement are the three most common mechanical complications associated with intravenous catheters.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

MarketResearchNest.com is the most comprehensive collection of market research products and services on the Web. We offer reports from almost all top publishers and update our collection on daily basis to provide you with instant online access to the world’s most complete and recent database of expert insights on global industries, organizations, products, and trends.

Event Details

PULSUS group cordially welcomes researchers, academicians, students and business professionals in the field of Cancer Science and Therapy from around

more

Event Details

PULSUS group cordially welcomes researchers, academicians, students and business professionals in the field of Cancer Science and Therapy from around the world to participate in the upcoming “2nd World Congress on Advanced Cancer Science & Therapy” to be held at Dubai, UAE during January 28-29, 2019. The meeting for this year will revolve around the theme “An Assembly of Curious Facts and Cure for Cancer” thus relaying the most cutting-edge findings in this field.

The two-day meeting is going to be an event to look forward for its enlightening symposiums & workshops from established experts in cancer therapy, potential keynote talks from eminent speakers, informative oral sessions and innovative poster presentations.

Cancer Therapy 2019 is an extraordinary event that invites participants from different leading universities, clinical research institutions and various diagnostic companies to share their research experiences in all aspects of this rapidly expanding field and provides an opportunity to meet and communicate with leading doctors, surgeons, scientists, academic professionals from around the world and listen to top speakers on new developments that impact and advance future of cancer science. It serves as a global platform to know about the current developments and new approaches in the field of cancer science and therapy. It will also prove to be a brilliant open door for businesses keen on expanding their global market reach. This event is an effort to understand the underlying new techniques which are amended to increase effectiveness, accuracy, sustainability, and quality of life.